バイオテクノロジー、医薬品開発、およびドラッグデリバリーシステム市場における世界のナノ粒子市場は、2023年から2028年までの予測期間中8.8%のCAGRで成長し、2023年の1,027億ドルから2028年までに1,568億ドルに達すると予想されます。
目次
Chapter- 1: Introduction
Study Goals and Objectives
Reasons for Doing This Study
What's New in This Report?
Scope of Report
Methodology
Market Estimate
Information Sources
Geographic Breakdown
Market Segmentation
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter- 2: Summary and Highlights
Table 0A : Global Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Application, Through 2028
Figure 0A : Global Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Application, 2020-2028
Table 0B : Global Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Technology, Through 2028
Figure 0B : Global Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Technology, 2020-2028
Chapter- 3: Market Overview
Introduction to Nanoparticles
Macromolecule Nanoparticles
Brief History of Nanoparticles
Nanoparticles in Biotechnology
Nanoparticles in Drug Development
Nanoparticles in Drug Delivery Systems
Nanoparticles in Diagnostic Imaging
Major Players in the Nanoparticle Drug Delivery Field
Major Nanoparticle/Nanocrystal Drugs
Market Dynamics
Regulatory Landscape
Emerging Technologies in Nanoparticles
Chapter- 4: Role of Nanotechnology in COVID-19 Vaccine Production
Introduction
Fight Against Novel Coronavirus
Structure of COVID-19 and Penetration
Challenges for COVID-19 Vaccines
Components and Methods in the Design of Vaccines
Next-Generation Vaccines Enabled Through Advances in Nanotechnology
Conclusion on Nanotechnology Use Against COVID-19
Chapter- 5: Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems by Technology
Technology Overview
Chapter- 6: Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems by Application
Biotechnology
Drug Development and Formulation
Drug Delivery Systems
Diagnostic Imaging
Table 16 : Global Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Application, Through 2028
Chapter- 7: Structure of Nanoparticles
Adoption of Nanoparticles in Applied Markets
Liquid Crystals
Liquid Carriers
Liposomes
Dendrimers
Chitosan and Alginate
Nanocrystals
Quantum Dots
Application of Nanoparticles to Drugs Delivered
Chapter- 8: Production of Nanoparticles
Methods of Nanoparticle Formation
Methods of Drug Introduction
Methods for Loading Biological Molecules into Nanoparticles
Nanocrystal Drugs
Problems with Large-Scale Nanoparticle Production
Chapter- 9: Nanoparticles in Biotechnology
Research and Development
Nanoparticle Research Collaborative Programs
Table 24 : Nanoparticles in Biotechnology Applications
Chapter- 10: Nanoparticles in Drug Development and Formulation
Bio Separations
Rapid Drug Analysis
Removal of Impurities and Toxins
Using Nanoparticles to Incorporate Insoluble Drugs
Gold and Silver Nanoparticles in Biomedicine
DNA Nanoparticle Development of DNA-Specific Drugs
Table 27 : Nanoparticles in Drug Development Applications
Chapter- 11: Nanoparticles in Drug Delivery Systems
Nanoparticles in Drug Delivery Applications
Designing a Nanoparticle Drug Delivery System
Methods of Administration of Nanoparticle Drugs
Nanoparticle Drug Delivery Systems Now Available
Chapter- 12: In Vitro and In Vivo Diagnostic Imaging
In Vitro Imaging
Nanoparticles in Diagnostic Imaging
Chapter- 13: Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems by Region
Market Overview and Discussion
North America
Europe
Asia-Pacific
Rest of the World
Chapter- 14: Competitive Landscape
Nanoparticle Drug Delivery Systems and Products
Major Players in Nanoparticle Drug Delivery Systems
Company Pipelines for Nanoparticle Drug Delivery
Drivers of Nanoparticle Products and Marketing
Limiters of Nanoparticle Product Development and Marketing
Chapter- 15: Patents, Licensing, Mergers and Acquisitions
Recent Licensing Activity, Mergers, and Acquisition
Recent Deals
Nanoparticle Patents
Chapter- 16: Company Profiles
BRISTOL-MYERS SQUIBB CO.
CAMURUS AB
CERAMISPHERE HEALTH PTY LTD.
CYTIMMUNE SCIENCES
GILEAD SCIENCES INC.
GLAXOSMITHKLINE PLC
HOFFMANN-LA ROCHE INC.
MERCK & CO. INC.
NANOCARRIER CO., LTD.
NOVARTIS AG